The FDA recently announced its plan to phase out the animal testing requirement for monoclonal antibodies (mAbs) and other drugs, instead opting to use human-relevant new approach methodologies (NAMs) ...
Microsoft has announced extensive enhancements for Azure, primarily targeting companies with high demands for data sovereignty and resilience. The focus is particularly on hybrid scenarios and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback